Artrya (ASX:AYA): SAPPHIRE partner Huntsville Hospital Health System signs 5 year commercial agreement; investor call Wednesday
Artrya announced on Friday that it had signed a five-year commercial agreement with SAPPHIRE partner Huntsville Hospital Health System. Huntsville...
86 Views
Artrya (ASX:AYA): Share price dragged down by EchoIQ FDA denial; AYA joins S&P/ASX 300; Scenario test the robustness of our forecasts maintain $6.07 per share valuation
Artrya fell -21% last week and at one point, was down another -8% today. At today’s close, the shares are down -50% from their all-time high of...
104 Views
Artrya (ASX:AYA): Downgrade valuation, but market overraction represents buying opportunity
The market responded negatively to Artrya’s 4Q26 cash flows today, closing down -16%. While there was some frustration in the delay in realising...
154 Views
Artrya (ASX:AYA): Disappointing 4Q26 cash flow
Artrya released its 4Q26 cash flow report today. Overall, it was a disappointing read (shares closed down -6.3%), with cash receipts below...
248 Views
Artrya (ASX:AYA): On track to join the ASX300 in September
AYA on track to join ASX 300 Artrya is on track to join the S&P ASX 300 index when it is rebalanced in September. At current market prices,...
119 Views